U.S. President Donald Trump addresses a coronavirus disease (COVID-19) pandemic briefing in the Brady Press Briefing Room of the White House in Washington, U.S., August 5, 2020.
Joshua Roberts | Reuters
President Donald Trump will sign an executive order requiring the U.S. government to buy “essential” drugs from American companies, White House trade advisor Peter Navarro announced Thursday.
The president is expected to sign the order during his trip in Ohio later Thursday, Navarro told reporters on a conference call. “If we’ve learned anything from the China virus pandemic, it is that we are dangerously over-dependent on foreign nations for our essential medicines, for medical supplies like masks gloves, goggles and medical equipment like ventilators.”
The order will require the U.S. government to develop a list of essential medicines and buy them as well as medical supplies from U.S. companies instead of from foreign countries like China, Navarro said. The World Health Organization already has a list of essential medicines, but the U.S. won’t need some of those drugs because of “where we are located,” he said.
The order will also remove some of the regulations U.S. pharmaceutical manufacturers face and fast-track the review process to make certain drug ingredients, he said. “For example, in terms of inspections the FDA makes, the FDA can walk in any pharmaceutical manufacturer in the U.S. unannounced and inspect. If they try to do that in China or India, these governments would tell them to come back and maybe we’ll let you in.”
Another component will “combat” the importation of counterfeit medicines on e-commerce platforms, he said.
The order comes as the U.S. continues to fight the coronavirus, which has infected nearly 5 million Americans and killed at least 158,268, according to data compiled by Johns Hopkins University.
Early in the outbreak, the FDA warned consumers of disruptions to the medical supply chain, including shortages of prescription drugs and critical medical products in the United States. The U.S. has faced a shortage of some medicines as some of the pharmaceutical ingredients were made predominantly by China.
Last month, Trump announced a $765 million deal with Kodak to make ingredients needed to make generic drugs in response to the pandemic.
This order is just the latest executive order from Trump on drugs. Late last month, he signed four executive orders designed to bring U.S. drug prices at least on par with their costs overseas.